APA (7th ed.) Citation

Ong, H. W., Yang, X., Smith, J. L., Taft-Benz, S., Howell, S., Dickmander, R. J., . . . Willson, T. M. (2024). Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2. Molecules, 29(17), 4158. https://doi.org/10.3390/molecules29174158

Chicago Style (17th ed.) Citation

Ong, Han Wee, et al. "Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2." Molecules 29, no. 17 (2024): 4158. https://doi.org/10.3390/molecules29174158.

MLA (9th ed.) Citation

Ong, Han Wee, et al. "Strategic Fluorination to Achieve a Potent, Selective, Metabolically Stable, and Orally Bioavailable Inhibitor of CSNK2." Molecules, vol. 29, no. 17, 2024, p. 4158, https://doi.org/10.3390/molecules29174158.